Grapefruit USA, Inc. (OTCQB:GPFT), announced that its notice of new cannabis product (“NNCP”), filed with Health Canada on Jan. 11, 2022, was approved by Health Canada on March 21, 2022, under NNCP ID No. NP-V2EHUWO907. As a result, Grapefruit is now authorized to sell its patented Hourglass Time Release THC+CBD infused topical delivery cream to licensed retail outlets throughout Canada.
Grapefruit believes its Hourglass THC/CBD delivery cream will fundamentally change the way humans safely ingest THC, CBD and other cannabinoids to enjoy their holistic benefits without exposure to the dangers of smoking and/or orally ingesting THC, CBD and other cannabinoids. A simple application of Grapefruit’s Hourglass THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids.
